Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2020-01-09 Capital/Financing Update
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a FORM 51-102F3 MATERIAL CHANGE REPORT, which is a regulatory filing used in Canadian securities regulation to disclose material changes in a company. The content describes the closing of a non-brokered private placement, including details of the offering, units issued, warrants, and use of proceeds. It is not a full financial report but an announcement of a material change event related to financing. The document length is 7477 characters, which is relatively short and focused on a specific event rather than comprehensive financial data or management discussion. This fits the category of Capital/Financing Update (CAP), as it provides an update on company fundraising activities and capital structure changes. Therefore, the appropriate classification is CAP with high confidence.
2020-01-09 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Avivagen Inc. has commenced trading on the OTCQB Venture Market in the U.S. It discusses the trading symbol, the benefits of the listing, and provides company background and product information. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is an announcement about a capital market event (listing on OTCQB) rather than a report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as new market listings.
2020-01-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a $1.25 million private placement by Avivagen Inc. It details the issuance of units, the price per unit, the use of proceeds, and related terms such as finder's fees and warrants. There is no financial statement or detailed financial analysis included, nor is there any mention of an annual or interim report. The content focuses on fundraising and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is sufficient and the content is consistent with a financing announcement rather than a regulatory filing or report publication announcement.
2020-01-03 English
News release - English.pdf
Regulatory Filings
2019-12-20 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2019-12-20 English
Annual MD&A - English.pdf
Regulatory Filings
2019-12-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.